Log in to save to my catalogue

Mixed Medicinal Mushroom Mycelia Attenuates Alzheimer’s Disease Pathologies In Vitro and In Vivo

Mixed Medicinal Mushroom Mycelia Attenuates Alzheimer’s Disease Pathologies In Vitro and In Vivo

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d1fa0320b10e4f7e9f537ce0b62f9c29

Mixed Medicinal Mushroom Mycelia Attenuates Alzheimer’s Disease Pathologies In Vitro and In Vivo

About this item

Full title

Mixed Medicinal Mushroom Mycelia Attenuates Alzheimer’s Disease Pathologies In Vitro and In Vivo

Publisher

MDPI

Journal title

Current issues in molecular biology, 2023-08, Vol.45 (8), p.6775-6789

Language

English

Formats

Publication information

Publisher

MDPI

More information

Scope and Contents

Contents

Alzheimer’s disease (AD) is characterized by memory impairment and existence of amyloid-β (Aβ) plaques and neuroinflammation. Due to the pivotal role of oxidative damage in AD, natural antioxidative agents, such as polyphenol-rich fungi, have garnered scientific scrutiny. Here, the aqueous extract of mixed medicinal mushroom mycelia (MMMM)—Phellinu...

Alternative Titles

Full title

Mixed Medicinal Mushroom Mycelia Attenuates Alzheimer’s Disease Pathologies In Vitro and In Vivo

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d1fa0320b10e4f7e9f537ce0b62f9c29

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d1fa0320b10e4f7e9f537ce0b62f9c29

Other Identifiers

ISSN

1467-3045,1467-3037

E-ISSN

1467-3045

DOI

10.3390/cimb45080428

How to access this item